Sumitomo Dainippon Pharma Co Ltd - Operating Expenses

Sumitomo Dainippon Pharma Co Ltd's Fiscal Year is From April To March - All Figures are in JPY, Billions.

The item "Operating-Expenses" stands at 194.08 Billion Japanese Yens for the trailing twelve months (TTM) period ending 09/30/2025, the lowest value at least since 03/31/2012, the period currently displayed.

Sumitomo Dainippon Pharma Co Ltd's second quarter result of 50.25 Billion JPY for the item "Operating Expenses" represents an increase of 14.65 percent compared to it's first quarter result.

Also, Sumitomo Dainippon Pharma Co Ltd's second quarter result of 50.25 Billion JPY for the item "Operating Expenses" represents a decrease of -13.04 percent compared to it's second quarter result of last year.

Looking again at the trailing twelve months series (TTM), Sumitomo Dainippon Pharma Co Ltd's second quarter result of 194.08 Billion JPY for the item "Operating Expenses" represents a decrease of -3.74 percent compared to it's first quarter result.


Regarding the One-Year-Change of the series, the current value constitutes a decrease of -59.57 percent compared to the value the year prior.
The 1 year change in percent is -59.57.
The 3 year change in percent is -54.73.
The 5 year change in percent is -36.49.
The 10 year change in percent is -25.06.

The Serie's long term average value is 295.32 Billion Japanese Yens. It's latest available value, on 09/30/2025, is 34.28 percent lower, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 09/30/2025, to it's latest available value, on 09/30/2025, is +0.0%.
The Serie's change in percent from it's maximum value, on 03/31/2024, to it's latest available value, on 09/30/2025, is -64.20%.